Jade Stohl

Clinical Program Manager, CND Life Sciences

With over a decade of invaluable experience in clinical research, predominantly within the dynamic field of neuroscience, Jade Stohl became a pivotal addition to CND Life Sciences in November 2020. Her remarkable journey has been characterized by unwavering dedication to the pursuit of medical excellence.

Jade's achievements include the successful completion of the NIH-sponsored Syn-One Study, encompassing 500 subjects across 20 sites in the United States. This groundbreaking research focuses on patients diagnosed with synucleinopathies, including Parkinson's disease, multiple system atrophy, dementia with Lewy bodies, and pure autonomic failure. Furthermore, CND Life Sciences has been awarded two NIH grants for their Syn-D Study, concentrated on patients diagnosed with Alzheimer's disease and dementia with Lewy Bodies at the Mild Cognitive Impairment (MCI) stage of the disease, and the Syn-Sleep Study, catering to patients with a diagnosis of Rapid Eye Movement Sleep Behavior Disorder (RBD).

Jade's extensive expertise in clinical research firmly establishes her as a key contributor to the progress of scientific knowledge and the enhancement of patient care. She brings a wealth of knowledge and experience, making complex concepts accessible and inspiring her audience to engage in the journey of scientific discovery and innovation. Jade Stohl is dedicated to improving healthcare, especially in the understanding and treatment of neurodegenerative diseases.